European CRO Genae stretches out in the U.S.

Belgian researcher Genae has expanded its U.S. presence with an office in New York City, part of its strategy to capitalize on the North American market for clinical trials. The new outpost comes on the heels of Genae's 2011 move to make U.S. landfall through a Cleveland clinical headquarters, and the company has been steadily expanding its operations around the globe over the past year. More

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.